Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.71 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.71 |
| ▸ | SRC | P12931 | 2/20 | 0.71 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.71 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.71 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.71 |
| ▸ | LDHA | P00338 | 1/20 | 0.71 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.71 |
| ▸ | FBP1 | P09467 | 1/20 | 0.71 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.71 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.71 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.71 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.71 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.71 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.71 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.71 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11584743 | 1.00 | P2RY1 (0.71) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL5550634 | 1.00 | P2RY1 (0.71) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL31001632 | 1.00 | P2RY1 (0.71) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL1069794 | 0.92 | P2RY1 (0.66) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL23982336 | 0.91 | MARS1 (0.60) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL6237505 | 0.91 | MARS1 (0.60) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL6237498 | 0.91 | MARS1 (0.60) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL1757017 | 0.90 | ADORA1 (0.73) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL2463542 | 0.90 | PRKACA (0.73) | P2RY1ADORA1SMN1; SMN2P2RY2SRC | |
| SCHEMBL9426538 | 0.90 | PRKACA (0.73) | P2RY1ADORA1SMN1; SMN2P2RY2SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118580307-B | Pro.AH8 acetyl hexapeptide-8 with tightening and anti-wrinkle effects, and preparation method and application thereof | 广东合鸣生物科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-118580307-A | Pro.AH8 acetyl hexapeptide-8 with tightening and anti-wrinkle effects, and preparation method and application thereof | 广东合鸣生物科技有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-113521091-A | Pharmaceutical composition for preventing or treating heart diseases and application thereof | 睿纳(珠海横琴)生物科技有限公司 | 2021-10-22 | — | — | CN | claimed |
| US-11149271-B2 | Method and pharmaceutical composition for treating cancer | INCREASEPHARM (HK) LIMITED (HK) | 2021-10-19 | — | — | US | claimed |
| CN-110870871-B | Methods and pharmaceutical compositions for treating cancer | 澳门科技大学 | 2021-09-07 | — | — | CN | claimed |
| WO-2021035391-A1 | USE OF TRANSFER RNA MOLECULE AND FRAGMENT THEREOF IN PREVENTION OR TREATMENT OF HEART DISEASE | 澳门科技大学 | 2021-03-04 | — | — | WO | claimed |
| US-20210052630-A1 | Methods and Compositions for Preventing or Treating Heart Disease | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2021-02-25 | — | — | US | claimed |
| CN-111419867-A | Use of transport RNA molecules and fragments thereof for preventing or treating cardiac diseases | 澳门科技大学 | 2020-07-17 | — | — | CN | claimed |
| CN-110870871-A | Methods and pharmaceutical compositions for treating cancer | 澳门科技大学 | 2020-03-10 | — | — | CN | claimed |
| US-20200071695-A1 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | INCREASEPHARM (HK) LIMITED (HK) | 2020-03-05 | — | — | US | claimed |
| US-8088752-B2 | Methods for metabolic modulation | VDF FUTURECEUTICALS, INC. (US) | 2012-01-03 | — | — | US | claimed |
| WO-2026107144-A1 | RNA SEQUENCE FOR EXPRESSING PROTEIN IN CARDIOMYOCYTES | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-118580307-B | Pro.AH8 acetyl hexapeptide-8 with tightening and anti-wrinkle effects, and preparation method and application thereof | 广东合鸣生物科技有限公司 | 2025-05-27 | — | — | CN | disclosed |
| WO-2025072615-A1 | IMPROVED METHODS OF MAKING RNA BY SPLINTED LIGATION AND COMPOSITIONS THEREOF | ORBITAL THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-118580307-A | Pro.AH8 acetyl hexapeptide-8 with tightening and anti-wrinkle effects, and preparation method and application thereof | 广东合鸣生物科技有限公司 | 2024-09-03 | — | — | CN | disclosed |
| WO-1997030713-A1 | METHOD AND COMPOSITION FOR INHIBITING CELLULAR IRREVERSIBLE CHANGES DUE TO STRESS | GALILEO LABORATORIES, INC. (US) | 1997-08-28 | — | — | WO | disclosed |
| EP-0670845-A1 | PROCESS FOR THE PREPARATION OF FLUDARABINE PHOSPHATE FROM GUANOSINE | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-09-13 | — | — | EP | disclosed |
| EP-0666910-A1 | METHOD OF CLEAVING SPECIFIC STRANDS OF RNA | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-08-16 | — | — | EP | disclosed |
| WO-1994012514-A1 | PROCESS FOR THE PREPARATION OF FLUDARABINE PHOSPHATE FROM GUANOSINE | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-06-09 | — | — | WO | disclosed |
| WO-1994009129-A2 | METHOD OF CLEAVING SPECIFIC STRANDS OF RNA | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-04-28 | — | — | WO | disclosed |